Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: A case series

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 7, 2012, Pages 756-758

  Barreiro De Acosta, Manuel ^a   García Bosch, Orlando ^b   Gordillo, Jordi ^c   Mañosa, Miriam ^d   Menchén, Luis ^e   Souto, Raquel ^a   Marin Jimenez, Ignacio ^e  

^a Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Santa Creu i Sant Pau ^*  (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

adalimumab; infliximab; pouchitis

Indexed keywords

ADALIMUMAB; INFLIXIMAB;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; COLON RESECTION; DEFECATION URGENCY; DIARRHEA; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERITIS; FAMILY HISTORY; FEMALE; HUMAN; ILEITIS; ILEOSTOMY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROCTITIS; PROCTOCOLECTOMY; REMISSION; RETROSPECTIVE STUDY; SMOKING; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; COLITIS, ULCERATIVE; DRUG EVALUATION; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; POUCHITIS; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862236716     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283525a7b     Document Type: Article

References (15)

1. Stange EF, Travis SPL, Vermeire S, ReinischW, Geboes K, Barakauskiene A, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008; 2:1-23.
2. Nicholls RJ, Clark DN, Kelso L, Crowe AM, Knight AD, Hodgkins P, et al. Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. Aliment Pharmacol Ther 2010; 31:1310-1321.
3. Johnson MW, Das P, Dewar DH, Forbes A, Ciclitira PJ, Nicholls RJ. Medical management of patients with ileal pouch anal anastomosis after restorative procto-colectomy. Eur J Gastroenterol Hepatol 2009; 21:9-17.
4. Holubar SD, Cima RR, SandbornWJ, Pardi DS. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev 2010; CD001176.
5. Ferrante M, D'Haens G, Dewit O, Baert F, Holvoet J, Geboes K, et al. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series. Inflamm Bowel Dis 2010; 16:243-249.
6. Viscido A, Habib FI, Kohn A, Papi C, Marcheggiano A, Pimpo MT, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003; 17:1263-1271.
7. Calabrese C, Gionchetti P, Rizzello F, Liguori G, Gabusi V, Tambasco R, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008; 27:759-764.
8. Barreiro-de Acosta M, García-Bosch O, Souto R, Mañosa M, Miranda J, García-Sanchez V, et al. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study. Inflamm Bowel Dis 2011. doi: 10.1002/ibd.21821.
9. ReinischW, SandbornWJ, Hommes DW, D'Haens G, Hanauer S, Schreiber S, et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut 2011; 60:780-787.
10. Barreiro-de Acosta M, Lorenzo A, Dominguez-Muñoz JE. Adalimumab in ulcerative colitis: two cases of mucosal healing and clinical response at two years. World J Gastroenterol 2009; 15:3814-3816.
11. Peyrin-Biroulet L, Laclotte C, Roblin X, Bigard M. Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. World J Gastroenterol 2007; 13:2328-2332.
12. Shen B, Remzi FH, Lavery IC, Lopez R, Queener E, Shen L, et al. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. Aliment Pharmacol Ther 2009; 29:519-526.
13. Lichtenstein GR, Cohen R, Yamashita B, Diamond RH. Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. J Clin Gastroenterol 2006; 40:669-677.
14. Gionchetti P, Straforini G, Tambasco R, Brugnera R, Fornarini G, Poggioli G, et al. Use of infliximab and adalimumab in refractory pouchitis. Gastroenterology 2010; 138 (Suppl 1):S328.
15. Colombel JF, SandbornWJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007; 132:52-65.